TipRanks on MSN
Amgen Inc Reports Strong Q3 Earnings and Strategic Growth
Amgen Inc (($AMGN)) has held its Q3 earnings call. Read on for the main highlights of the call. Amgen Inc’s recent earnings ...
Investor's Business Daily on MSN
Amgen Surges On Broad-Based Beat As Investors Zone In On Obesity
Amgen stock popped Wednesday on a solid third-quarter beat as investors focus on what's next for the company's obesity ...
--Traded as high as $316.98; highest intraday level since March 24, 2025, when it hit $317.58 --Up 6.84% at today's intraday high; largest intraday percent increase since Oct. 1, 2025, when it rose as ...
Amgen remains a compelling long-term buy, supported by robust R&D investment and a promising drug pipeline for future growth.
With its biosimilars business thriving, Amgen isn’t a fan of changes proposed by HHS Secretary Robert F. Kennedy Jr. | With its biosimilars business thriving, Amgen isn’t a fan of changes proposed by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results